Enanta Pharmaceuticals, Inc. (ENTA)
14.25
+0.14
(+0.99%)
USD |
NASDAQ |
Apr 13, 13:27
Enanta Pharmaceuticals Market Cap : 413.53M for April 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cyclerion Therapeutics, Inc. | 12.90M |
| ACADIA Pharmaceuticals, Inc. | 3.591B |
| Alnylam Pharmaceuticals, Inc. | 43.39B |
| Savara, Inc. | 1.216B |
| BioMarin Pharmaceutical, Inc. | 10.43B |
Market Cap Related Metrics
| PS Ratio | 4.939 |
| Price to Book Value | 3.267 |
| Price | 14.25 |
| Earnings Yield | -22.49% |